🇺🇸 FDA
Patent

US 10093694

Compounds for treating eye disorders or diseases

granted A61PA61P27/12

Quick answer

US patent 10093694 (Compounds for treating eye disorders or diseases) held by The Regents of the University of California expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P27/12